Medusahead [Taeniatherum caput-medusae (L.) Nevski] is an invasive annual grass spreading into rangelands throughout the western United States. We tested cattle (Bos taurus L.) utilization of T. caput-medusae following treatment with glyphosate in two forms of its salt (potassium salt and isopropylamine salt) at three different rates of application; low (236 g ae ha-1), medium (394 g ae ha-1), and high rates (788 g ae ha-1) in eastern Washington. The herbicide was applied on April 26, 2016. A second location, northern Utah, was treated with glyphosate in the form of its isopropylamine salt at the high rate. The herbicide was applied on June 5, 2019. Cattle were allowed to start grazing T. caput-medusae 15 d after glyphosate treatment and had unlimited access to the glyphosate-treated plots for more than 85 d. The greatest utilization of T. caput-medusae occurred at the highest glyphosate application rate (P < 0.05), in Washington, with no difference between forms of glyphosate salt. Cattle also consumed T. caput-medusae at the Utah site (P < 0.05). Glyphosate treatment preserved the water-soluble carbohydrate content of T. caput-medusae at levels greater than the nontreated controls (P < 0.05) at both locations. The glyphosate treatment assisted in the increased utilization of T. caput-medusae by cattle and is a viable option for the reduction of T. caput-medusae while increasing the forage value of the weed.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.